NIH Reporter #RFA-CA-22-041

NIH Grant for Research on EMT Plasticity and Immune Dysfunction in Pancreatic Cancer

This opportunity from the National Cancer Institute (NCI), part of the NIH, invites grant applications for research on chromatin regulation and immune response in pancreatic ductal adenocarcinoma. - Government Buyer: - National Institutes of Health (NIH) - National Cancer Institute (NCI) - Project Location: - Massachusetts General Hospital, Boston, MA - Focus Areas: - Chromatin regulation in pancreatic cancer - Tumor heterogeneity - Epithelial-mesenchymal transition (EMT) plasticity - Immune evasion mechanisms - Funding: - Total grant value: $107,535 for fiscal year 2025 - Requirements: - Research must address EMT plasticity and immune dysfunction in pancreatic ductal adenocarcinoma - No specific products, OEMs, or vendors are requested - Classification: - Cancer, General (code 93.398) - Notable: - No equipment or service procurement; this is a research grant opportunity

Description

This NIH grant opportunity issued by the National Cancer Institute (NCI) focuses on investigating chromatin regulation and immune response mechanisms in pancreatic ductal adenocarcinoma. The project aims to elucidate mechanisms of tumor heterogeneity, epithelial-mesenchymal transition (EMT) plasticity, and immune evasion. The grant has a total cost of $107,535 for fiscal year 2025 and covers a project duration from September 1, 2024, to August 31, 2028. The organization involved is Massachusetts General Hospital located in Boston, MA.

View original listing